Skip to content

GS PHARMA: what changed

BE 0848.422.277NACE 47.730, Retail sale of pharmaceutical productsOther company

Position among the sector peers

What moved between 2024 and 2025

Net result for the year
€124,005
2024 · €15,644+€108,361
Equity
€148,356
2024 · €148,351+€5
Cash
€17,075
2024 · €62,168-€45,093
Balance sheet total
€796,930
2024 · €801,776-€4,846

Largest movements

2024 to 2025
Assets
  • Receivables within one year +€50,869

    up €50,869 (+11.6%), from €438,619 to €489,488

    of which Other amounts receivable: +€35,515

  • Cash -€45,093

    down €45,093 (-72.5%), from €62,168 to €17,075

    mainly Contributions, distributions and other (-€124,000) and Trade debts (-€93,005)

  • Tangible fixed assets -€22,110

    down €22,110 (-42.4%), from €52,100 to €29,990

    of which Land and buildings: -€21,979

  • Stocks and contracts +€13,590

    up €13,590 (+5.8%), from €232,668 to €246,258

Equity and liabilities
  • Other debts +€125,060

    up €125,060 (+91.6%), from €136,578 to €261,638

  • Trade debts -€93,005

    down €93,005 (-47.5%), from €195,883 to €102,878

  • Debts after one year -€43,736

    down €43,736 (-33.1%), from €132,033 to €88,298

Income statement
  • Gross operating margin +€119,193

    up €119,193 (+66.2%), from €180,079 to €299,272

  • Staff costs +€14,550

    up €14,550 (+11.6%), from €125,445 to €139,996

  • Financial charges -€5,567

    down €5,567 (-34.5%), from €16,152 to €10,585

  • Financial income -€3,559

    down €3,559 (-85.2%), from €4,178 to €619

    of which Non-recurring financial income: -€1,997

Change in the result, 2024 to 2025

effect on the result

For each income-statement line you see the change as its effect on the result. Higher costs lower the result, higher income raises it.

Result 2024 €15,644
Gross operating margin +€119,193
Staff costs -€14,550
Depreciation +€1,220
Other operating charges +€51
Financial income -€3,559
Financial charges +€5,567
Taxes +€441
Result 2025 €124,005
raises the resultlowers the result

Derived cash bridge

cash 2024 to 2025

The bridge is derived from the 2024 and 2025 balance sheets and the 2025 result. There is no filed cash-flow statement. You see where the money came from and where it went.

From operations +€123,174
Investment -€1,752
Financing -€166,515
Cash 2024 €62,168
Net result for the year +€124,005
Depreciation +€23,862
Stocks and contracts -€13,590
Receivables within one year -€50,869
Deferred charges and accrued income +€2,102
Trade debts -€93,005
Tax, wage and social debts +€6,576
Other debts +€125,060
Accrued charges and deferred income -€967
Investment in fixed assets (net) -€1,752
Debts after one year -€43,736
Current portion of long-term debt +€1,221
Contributions, distributions and other -€124,000
Cash 2025 €17,075
brings cash intakes cash out
Every line side by side 47 lines
Line Code 2024 2025 Change %
Total assets 20/58 €801,776 €796,930 -€4,846 -0.6%
Fixed assets 21/28 €52,100 €29,990 -€22,110 -42.4%
Tangible fixed assets 22/27 €52,100 €29,990 -€22,110 -42.4%
Land and buildings 22 €50,934 €28,956 -€21,979 -43.2%
Plant, machinery and equipment 23 €1,166 €1,035 -€131 -11.3%
Current assets 29/58 €749,675 €766,939 +€17,264 +2.3%
Stocks and contracts in progress 3 €232,668 €246,258 +€13,590 +5.8%
Stocks 30/36 €232,668 €246,258 +€13,590 +5.8%
Amounts receivable within one year 40/41 €438,619 €489,488 +€50,869 +11.6%
Trade receivables 40 €72,763 €88,117 +€15,354 +21.1%
Other amounts receivable 41 €365,855 €401,371 +€35,515 +9.7%
Cash at bank and in hand 54/58 €62,168 €17,075 -€45,093 -72.5%
Deferred charges and accrued income 490/1 €16,221 €14,119 -€2,102 -13.0%
Total equity and liabilities 10/49 €801,776 €796,930 -€4,846 -0.6%
Equity 10/15 €148,351 €148,356 +€5 0.0%
Contributions 10/11 €20,000 €20,000 = 0.0%
Reserves 13 €128,351 €128,356 +€5 0.0%
Distributable reserves 133 €128,351 €128,356 +€5 0.0%
Amounts payable 17/49 €653,425 €648,574 -€4,851 -0.7%
Amounts payable after more than one year 17 €132,033 €88,298 -€43,736 -33.1%
Financial debts 170/4 €132,033 €88,298 -€43,736 -33.1%
Amounts payable within one year 42/48 €517,917 €557,769 +€39,852 +7.7%
Current portion of amounts payable after more than one year 42 €42,515 €43,736 +€1,221 +2.9%
Financial debts 43 €125,000 €125,000 = 0.0%
Credit institutions 430/8 €125,000 €125,000 = 0.0%
Trade debts 44 €195,883 €102,878 -€93,005 -47.5%
Suppliers 440/4 €195,883 €102,878 -€93,005 -47.5%
Taxes, remuneration and social security 45 €17,942 €24,518 +€6,576 +36.7%
Taxes 450/3 €1,528 €7,610 +€6,082 +398%
Remuneration and social security 454/9 €16,414 €16,908 +€494 +3.0%
Other amounts payable 47/48 €136,578 €261,638 +€125,060 +91.6%
Accrued charges and deferred income 492/3 €3,474 €2,507 -€967 -27.8%
Non-recurring operating income 76A €522 - -€522
Remuneration, social security and pensions 62 €125,445 €139,996 +€14,550 +11.6%
Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets 630 €25,082 €23,862 -€1,220 -4.9%
Other operating charges 640/8 €450 €400 -€51 -11.3%
Gross operating margin 9900 €180,079 €299,272 +€119,193 +66.2%
Operating profit (loss) 9901 €29,102 €135,015 +€105,913 +364%
Financial income 75/76B €4,178 €619 -€3,559 -85.2%
Recurring financial income 75 €2,181 €619 -€1,563 -71.6%
Non-recurring financial income 76B €1,997 - -€1,997
Financial charges 65/66B €16,152 €10,585 -€5,567 -34.5%
Recurring financial charges 65 €16,152 €10,585 -€5,567 -34.5%
Profit (loss) for the period before taxes 9903 €17,128 €125,048 +€107,920 +630%
Income taxes 67/77 €1,484 €1,043 -€441 -29.7%
Profit (loss) for the period 9904 €15,644 €124,005 +€108,361 +693%
Profit (loss) for the period to be appropriated 9905 €15,644 €124,005 +€108,361 +693%

Value

latest balance sheet 31-12-2025 · indication, not a valuation or advice

Indicative value of the equity

Indication, not a valuation or advice
€274,603 to €354,773

Midpoint €308,007 · 50% capitalised earnings, 50% adjusted equity

Capitalisation rate 12% result over 3 years, excluding non-recurring income and charges earnings weight 50%

Worked out with Checked's starting values, not your estimate and not market data. Change the assumptions: the value follows.

Adjusted equity €148,356
Capitalised earnings €400,850 to €561,190
Indication €274,603 to €354,773

Adjusted equity

balance sheet 31-12-2025
Equity (10/15)
€148,356
Revaluation of assets
€0
Deferred tax on the revaluation
€0
Other adjustment
€0
Adjusted equity
€148,356

Capitalised earnings

net result for the year (9904)
2025
€124,005
2024
€15,644
excluding non-recurring income and charges
€13,126
2023
€31,225
2022
€2,333
2021
-€21,116
Average result, excluding non-recurring income and charges
€56,119
Divided by the capitalisation rate
14% / 12% / 10%
Capitalised earnings
€400,850 / €467,658 / €561,190

Limits of the indication

  • Checked holds no market prices or comparable transactions.
  • Anything after the latest accounts and items off the balance sheet (guarantees, leases, disputes) are left out.
  • Checked does not know the real value of buildings, stock and receivables. Enter your own revaluation or adjustment for it.
  • The result is not corrected for the manager's pay. If the company pays less or more than a market salary, the capitalised earnings are too high or too low.
  • The owner's role in the business, synergies for a buyer and the tax consequences of a sale are left out.

For a valuation to base a decision on, go to a company auditor or a certified accountant.

Calculation and sources

Source: filed annual accounts (NBB) and main activity (KBO). The movements compare the financial years ended 31 December 2024 and 31 December 2025. Green is a favourable move for that line, red an unfavourable one. The value is an indication, not a valuation or advice. Prepared on 19 November 2026 via checked.be.